We are live on ! Find out more
CPIX icon

Cumberland Pharmaceuticals
CPIX

41 hedge funds and large institutions have $30.1M invested in Cumberland Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

33.88% more ownership

Funds ownership: 0% → 33.88% (+34%)

11% more capital invested

Capital invested by funds: $27.1M → $30.1M (+$3.02M)

3% more funds holding

Funds holding: 40 → 41 (+1)

14% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 14

Holders
41
Holders Change
+1
Holders Change %
+2.5%
% of All Funds
1.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
12
Reduced
14
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
+$1.54M
2
New York State Common Retirement Fund
New York State Common Retirement Fund
New York
+$69.9K
3
BIT
BlackRock Institutional Trust
California
+$61.6K
4
Renaissance Technologies
Renaissance Technologies
New York
+$51.6K
5
AA
Ancora Advisors
Ohio
+$18.8K

Top Sellers

Rank Fund Capital Flow
1
AI
Ariel Investments
Illinois
-$1.17M
2
UCFA
United Capital Financial Advisors
Texas
-$139K
3
Morgan Stanley
Morgan Stanley
New York
-$65.1K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$38.1K
5
Invesco
Invesco
Georgia
-$13K
Name Holding Trade Value Shares
Change 		Change in
Stake
BA
26
BlackRock Advisors
Delaware
$25K – – –
NFA
27
Nationwide Fund Advisors
Ohio
$21K – – –
Deutsche Bank
28
Deutsche Bank
Germany
$21K +$11.9K +2,282 +135%
AA
29
Ancora Advisors
Ohio
$20K +$18.8K +3,600 New
OC
30
Oakworth Capital
Alabama
$17K – – –
TDC
31
Thompson Davis & Co
Virginia
$12K +$10.4K +2,000 +1,000%
BIM
32
BlackRock Investment Management
Delaware
$10K – – –
UBS Group
33
UBS Group
Switzerland
$8K -$2.42K -465 -24%
MFS
34
MSI Financial Services
Massachusetts
$6K – – –
Manulife (Manufacturers Life Insurance)
35
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$4K -$1.16K -222 -25%
SEI Investments
36
SEI Investments
Pennsylvania
$3K +$913 +175 +54%
Walleye Trading
37
Walleye Trading
New York
$2K -$193 -37 -8%
MA
38
MUFG Americas
New York
$1K -$1.25K -240 -51%
GC
39
Globeflex Capital
California
$1K – – –
WIC
40
Woodmont Investment Counsel
Tennessee
– -$10K -2,000 Closed
TRCT
41
Tower Research Capital (TRC)
New York
– -$6.66K -1,276 -97%
Bank of America
42
Bank of America
North Carolina
– +$10 +2 New
1
2

CPIX Hedge Fund Activity: Q4 2016 in Review

41 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q4 2016, worth a combined $30.1M — up 11% from $27.1M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new CPIX positions and 1 closed out — a net gain of 2 holders — while 12 added to existing stakes and 14 trimmed.

The largest buyer was Stonepine Capital Management, adding an estimated $1.54M. The largest seller was Ariel Investments, cutting an estimated $1.17M.

  • 41 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q4 2016, up from 40 in Q3 2016.
  • Funds reported $30.1M of Cumberland Pharmaceuticals stock for Q4 2016, up 11% quarter-over-quarter.
  • 3 funds opened new Cumberland Pharmaceuticals positions in Q4 2016 and 1 closed out, a net change of +2 holders.
  • The largest Cumberland Pharmaceuticals buyer in Q4 2016 was Stonepine Capital Management, an estimated $1.54M added.
  • The largest Cumberland Pharmaceuticals seller in Q4 2016 was Ariel Investments, an estimated $1.17M sold.

Based on aggregated 13F filings for Q4 2016.